Who Are We?
dadcheck®gold belongs to Complement Genomics Ltd (www.compgeno.com) , a long established (April 2000), reliable, highly recommended and trusted DNA testing company.
dadcheck®gold is designed to give answers to paternity and relationship questions using DNA testing technology. This service is designed specifically for use by professionals from the legal sector, by Local Authorities and by social services.
We have our own UK based and ISO/IEC 17025 accredited laboratories, plus UK based customer services.
The ISO/IEC 17025 accreditation is a pre-requisite for inclusion on the Ministry of Justice list of companies who are recognised as “a body that may carry out parentage tests directed by the civil courts of England and Wales under section 20 of the Family Law Reform Act 1969”.
We are proud to say that we are indeed on the Ministry of Justice list and look forward to servicing your requirements for legally admissible data. This includes Family court proceedings, submissions to the Child Maintenance Service, the Child Support Agency, the Registrar of Births and the Home Office (Immigration).
We have also many years expertise in DNA testing for forensic purposes, which can be of help in resolving inheritance disputes.
Complement Genomics Ltd is research active and is developing new products in the field of wound care associated biomarkers (we work with the National Institute of Health Research, which is part of the UK’s Department of Health). This programme, in which we partner with the National Physical Laboratory, and Leeds Teaching Hospital Trust, is focused on helping diabetic foot ulcers to heal more rapidly. Treatment of wounds in the NHS uses 3% of the total healthcare budget and by carrying out this research, we hope to be able to develop new technology which can predict which wounds will heal quickly and which will not. Hence we will be able to recommend effective treatment and ensure that valuable NHS resources are not wasted on inappropriate treatments.
Our contract services
We also carry out genetic testing in the clinical research area (www.geneblitz.com). Amongst a range of state of the art services, one of our key areas of expertise in is drug metabolism, whereby we analyse for genetic changes which affect the ability of a patient to break down drugs, a key part of determnination of the correct dose of treatment for that patient.
In this regard we have won contracts with some of the worlds largest Contract Research Organisations (CROs), who are helping pharmaceutical companies to develop the next generation of life enhancing and life saving drugs.
Ms Louise Allcroft BSc., MSc., is the Chief Executive Officer and is a post graduate of Newcastle University in Medical Genetics, having carried our research into the genetics of colon cancer.
Louise is responsible for the day to day running of the company and is the authorised signatory. She is also the designated Quality Manager for ISO/IEC 17025.
She says,“ I take great pride in personally checking every report that leaves the company. Quality, high standards, efficiency and accuracy are paramount in all of our interactions with our customers”.
Dr Neil Sullivan BSc, MBA (DIC), LLM, PhD is the General Manager. He has been involved in genetic testing and molecular biology for over 30 years and is the author of over 40 original publications and two books. His current role in the company is in new business development and marketing.
He says, “Our continual commitment to improvement and to investment in new facilities and equipment puts us at the forefront of genetic testing technology. Our planned roll out of innovative new products and services represents an exciting time for the company”.
Have a question?Send us a message.
Our award winning customer service team will be pleased to help you.